Found 19 matching trials
A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX) PHASE3 The purpose of this study is to verify the superiority of ASP015K in combin...
Show More Learn More & Join Trial
Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease PHASE3 This is a multicenter, randomized, open-label study with an active standard...
Show More Location
Yale University School of Medicine
Learn More & Join Trial
The Individual Therapy for Patients With Wilson's Disease EARLY_PHASE1 Based on the genotype characteristics and genotype-phenotype-treatment prog...
Show More Location
econd Affiliated Hospital,Zhejiang University School of Medicine
Learn More & Join Trial
Cystine Capacity Clinical Study (CysCap) N/A The purpose of this study is to determine whether urinary cystine capacity,...
Show More Location
NYU Langone Medical Center
Learn More & Join Trial
Real World Evidence Study in Subjects With Wilson's Disease N/A This non-interventional Real-World Evidence (RWE) study aims to describe no...
Show More Location
UC Davis Midtown Ambulatory Care Centre
Learn More & Join Trial
Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria PHASE4 The purpose of this study is to evaluate the effect of escalating doses of ...
Show More Location
NYU Langone Medical Center
Learn More & Join Trial
Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine PHASE4 A study to review Wilson disease patients who have previously been prescrib...
Show More Location
Universitätsklinik Heidelberg
Learn More & Join Trial
Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis PHASE2 The narrowing of Dialysis Fistulae or Grafts is a near universal problem in...
Show More Location
Southeast Renal Research Institute
Learn More & Join Trial
The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment N/A This was a 24-month study to assess copper parameters in participants with ...
Show More Location
Clinical Trial Site
Learn More & Join Trial
Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease PHASE3 This study is being conducted to evaluate the efficacy, safety, pharmacokin...
Show More Learn More & Join Trial